Literature DB >> 9581663

Clinical characteristics and disease course of alcoholics with inactive aldehyde dehydrogenase-2.

M Murayama1, S Matsushita, T Muramatsu, S Higuchi.   

Abstract

Inactive aldehyde dehydrogenase-2 (ALDH2) is known as a genetic negative risk factor for the development of alcoholism. In alcoholics with inactive ALDH2, unidentified factors that overcome the adverse reactions of high blood acetaldehyde concentration after drinking may increase such persons' susceptibility to alcoholism. Comparison of clinical characteristics, including sociofamilial backgrounds and psychopathologies, failed to show significant differences between alcoholics with inactive ALDH2 (inactive group) and those with active ALDH2 (active group). Examination of the temporal profile of disease development showed that the inactive group experienced each stage or event in the history of drinking and alcoholism 1 to 5 years later in life than the active group; however, not all comparisons reached statistically significant levels. Although preliminary, these results suggest that an inactive ALDH2-mediated delay in the occurrence of alcohol-related problems seems to contribute to the suppression of alcoholism development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581663

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  6 in total

Review 1.  Pharmacogenetic studies of alcohol self-administration and withdrawal.

Authors:  John C Crabbe; Tamara J Phillips
Journal:  Psychopharmacology (Berl)       Date:  2003-10-09       Impact factor: 4.530

2.  Genetic testing for the susceptibility to alcohol dependence: interest and concerns in an African American population.

Authors:  Denise M Scott; Evaristus Nwulia; John Kwagyan; Gloria Cain; Vanessa J Marshall; Nnenna Kalu; Altovise Ewing; Robert E Taylor
Journal:  Genet Test Mol Biomarkers       Date:  2014-06-13

3.  Slow-metabolizing ADH1B and inactive heterozygous ALDH2 increase vulnerability to fatty liver in Japanese men with alcohol dependence.

Authors:  Akira Yokoyama; Nobuhito Taniki; Sachiko Hara; Emiko Haysashi; Nobuhiro Nakamoto; Takeshi Mizukami; Katsuya Maruyama; Tetsuji Yokoyama
Journal:  J Gastroenterol       Date:  2017-10-23       Impact factor: 7.527

4.  Pharmacological activation of aldehyde dehydrogenase 2 by Alda-1 reverses alcohol-induced hepatic steatosis and cell death in mice.

Authors:  Wei Zhong; Wenliang Zhang; Qiong Li; Guoxiang Xie; Qian Sun; Xiuhua Sun; Xiaobing Tan; Xinguo Sun; Wei Jia; Zhanxiang Zhou
Journal:  J Hepatol       Date:  2014-12-24       Impact factor: 25.083

Review 5.  Combining research approaches to advance our understanding of drug addiction.

Authors:  Marianne B M van den Bree
Journal:  Curr Psychiatry Rep       Date:  2005-04       Impact factor: 8.081

6.  Aldehyde Dehydrogenase 2 (ALDH2) Polymorphism and the Risk of Alcoholic Liver Cirrhosis among East Asians: A Meta-Analysis.

Authors:  Lei He; Tao Deng; Hesheng Luo
Journal:  Yonsei Med J       Date:  2016-07       Impact factor: 2.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.